Masahiro Onji

1.1k total citations
20 papers, 711 citations indexed

About

Masahiro Onji is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Masahiro Onji has authored 20 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Masahiro Onji's work include Immune Response and Inflammation (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Immune Cell Function and Interaction (4 papers). Masahiro Onji is often cited by papers focused on Immune Response and Inflammation (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Immune Cell Function and Interaction (4 papers). Masahiro Onji collaborates with scholars based in Japan, Austria and Canada. Masahiro Onji's co-authors include Kensuke Miyake, Ryutaro Fukui, Takuma Shibata, Atsuo Kanno, Shin-ichiroh Saitoh, Shin-ichiroh Saitoh, Nobuaki Yoshida, Toshiyuki Shimizu, Morikazu Onji and Umeharu Ohto and has published in prestigious journals such as Cell, Nature Communications and Immunity.

In The Last Decade

Masahiro Onji

20 papers receiving 702 citations

Peers

Masahiro Onji
Comparison fields: 5 of 72
  • Immunology 460
  • Molecular Biology 201
  • Rheumatology 114
  • Oncology 100
  • Epidemiology 97
Replace Christina M. Lau with:
Christina M. Lau United States
Sathi Babu Chodisetti United States
Stacey L. Mueller‐Ortiz United States
Katsuyuki Kitoh Japan
M. Kreisler Spain
H. Makni Tunisia
Chen‐Chung Chu Taiwan
Laura Horváth Hungary
Takafumi Okuno Japan
Christina M. Lau United States View profile →
Citations per field, relative to Masahiro Onji
Masahiro Onji · 1×
Citations per year, relative to Masahiro Onji
Masahiro Onji · 1×

Countries citing papers authored by Masahiro Onji

Since Specialization
Citations

This map shows the geographic impact of Masahiro Onji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Onji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Onji more than expected).

Fields of papers citing papers by Masahiro Onji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Onji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Onji. The network helps show where Masahiro Onji may publish in the future.

Co-authorship network of co-authors of Masahiro Onji

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Onji. A scholar is included among the top collaborators of Masahiro Onji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Onji. Masahiro Onji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 5
3 14
4 11
5 11
6 67
7 113
8 75
9 39
10 165
11 19
12 137
13 14
14
[Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
1
15
Increased levels of interleukin-12 in Graves’ disease
3
16
Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis.
26
17
[Approach to diagnosis of drug-induced liver diseases].
2
18
[A staining method of PIVKA-II by an indirect immunoenzyme technic].
2
19
STUDIES OF HBSAG POSITIVE CHRONIC HEPATITIS WITH SUBLOBULAR HEPATIC-NECROSIS - ITS OCCURRENCE AND PROGNOSIS
3
20
[Blood level of 5-fluorouracil (5-FU) by oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and tegafur in patients with hepatocellular carcinoma].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026